As CEO of Codexis, Alan Shaw led the development of cost-advantaged processes for production of biofuels, biobased chemicals and pharmaceuticals. During his tenure, Codexis completed an IPO and expanded from a startup to a global industrial biotechnology company with operations in the United States, Europe and Asia. Shaw brought with him his expertise as a veteran biotechnology entrepreneur and chemical industry executive, with more than 25 years experience building and leading technology companies.

Shaw is currently President and CEO of Claysta. He holds a bachelor’s degree in chemistry from Teesside University and a Ph.D. in chemistry from the University of Durham, England, and is a Fellow of the Royal Society of Chemistry and a Fellow of the Chartered Institute of Marketing.